Merck & Co's Lipfendra (enlicitide) employs 13 enzymes in biocatalytic synthesis.
Oral cholesterol-lowering peptide approved after a decade in development
Merck & Co's Lipfendra (enlicitide) employs 13 enzymes in biocatalytic synthesis.
Author: Chemistry World
Read Original Article